Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hoon Ji

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Nature Communications|August 16, 2024
DSS1 restrains BRCA2's engagement with dsDNA for homologous recombination, replication fork protection, and R-loop homeostasisYuxin Huang, Wenjing Li, Tzeh Foo, et al.
Journal of Gastroenterology and Hepatology|May 20, 2016
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinomaSoon Sun Kim, Ji Sun Nam, Hyo Jung Cho, et al.
Molecular Cell|August 4, 2019
The N-Degron Pathway Mediates ER-phagyChang Hoon Ji, Hee Yeon Kim, Ah Jung Heo, et al.
Nature Communications|October 24, 2018
ZZ-dependent regulation of p62/SQSTM1 in autophagyYi Zhang, Su Ran Mun, Juan F Linares, et al.
Nucleic Acids Research|October 6, 2021
USP39 promotes non-homologous end-joining repair by poly(ADP-ribose)-induced liquid demixingJae Jin Kim, Seo Yun Lee, Yiseul Hwang, et al.
Cell Death & Disease|October 26, 2021
p62/SQSTM1-induced caspase-8 aggresomes are essential for ionizing radiation-mediated apoptosisSu Hyun Lee, Won Jin Cho, Abdo J Najy, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2010
Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapyKyoung Ha Kim, In-Gu Do, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2005
Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II studyDo Hyoung Lim, Young Suk Park, Byeong-Bae Park, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2008
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancerKyoung Ha Kim, Young Suk Park, Myung Hee Chang, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancerMyung Hee Chang, Kyoung Ha Kim, Hyun Jung Jun, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Nature Communications|August 16, 2024
DSS1 restrains BRCA2's engagement with dsDNA for homologous recombination, replication fork protection, and R-loop homeostasisYuxin Huang, Wenjing Li, Tzeh Foo, et al.
Journal of Gastroenterology and Hepatology|May 20, 2016
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinomaSoon Sun Kim, Ji Sun Nam, Hyo Jung Cho, et al.
Molecular Cell|August 4, 2019
The N-Degron Pathway Mediates ER-phagyChang Hoon Ji, Hee Yeon Kim, Ah Jung Heo, et al.
Nature Communications|October 24, 2018
ZZ-dependent regulation of p62/SQSTM1 in autophagyYi Zhang, Su Ran Mun, Juan F Linares, et al.
Nucleic Acids Research|October 6, 2021
USP39 promotes non-homologous end-joining repair by poly(ADP-ribose)-induced liquid demixingJae Jin Kim, Seo Yun Lee, Yiseul Hwang, et al.
Cell Death & Disease|October 26, 2021
p62/SQSTM1-induced caspase-8 aggresomes are essential for ionizing radiation-mediated apoptosisSu Hyun Lee, Won Jin Cho, Abdo J Najy, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2010
Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapyKyoung Ha Kim, In-Gu Do, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2005
Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II studyDo Hyoung Lim, Young Suk Park, Byeong-Bae Park, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2008
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancerKyoung Ha Kim, Young Suk Park, Myung Hee Chang, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancerMyung Hee Chang, Kyoung Ha Kim, Hyun Jung Jun, et al.
Pageof 16